MediPharm Labs Corp. (LABS) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medipharm Labs Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.737 Thank you for standing by and welcome to the Mediform Labs conference call to discuss 00:00:04.737 -- 00:00:08.601 the company's 2026 Q1 results. 00:00:08.601 -- 00:00:14.228 Our speaker on today's call is Greg Hunter, Interim CEO and Chief Financial Officer. 00:00:14.228 -- 00:00:18.674 As a reminder, all participants are in a listen-only mode and the conference is being 00:00:18.674 -- 00:00:24.040 recorded. After management's presentation, we will take questions from the analyst community 00:00:24.040 -- 00:00:29.731 on the telephone and then take written questions through the Q&A feature on the webcast. 00:00:29.731 -- 00:00:33.517 The information during this call should be considered together with the more detailed 00:00:33.517 -- 00:00:39.287 information, disclosure, financial data, and statements available on the company's website 00:00:39.287 -- 00:00:43.110 and on the SetterPlus profile at setterplus.ca. 00:00:43.354 -- 00:00:48.102 As set out on the webcast slide, I would like to note that remarks during this earnings 00:00:48.102 -- 00:00:52.730 call may contain forward-looking information and forward-looking statements within the 00:00:52.730 -- 00:00:58.096 meaning of applicable security law. This includes, without limitation, statements 00:00:58.096 -- 00:01:03.524 about MediForm Labs and its current and future plans, expectations, intentions, 00:01:03.524 -- 00:01:08.572 financial results, operations, levels of activity, performance, goals 00:01:08.572 -- 00:01:13.920 or achievements, and other future events, trends, profitability, 00:01:13.920 -- 00:01:16.243 business growth, or developments. 00:01:16.243 -- 00:01:21.051 All statements other than statements of historical fact are forward-looking statements. 00:01:21...